What is ELV stock price today?

ELV (Elevance Health Inc) stock is trading at $393.44 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is ELV stock going up or down today?

ELV stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy ELV stock now?

The decision to buy ELV depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is ELV a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for ELV based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is ELV stock overvalued or undervalued?

ELV currently trades at a P/E ratio of 17.61 relative to earnings. Our DCF calculator provides intrinsic value estimates to help determine if ELV is fairly priced.

What is ELV's P/E ratio?

ELV has a price-to-earnings (P/E) ratio of 17.61, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is ELV's market cap?

ELV (Elevance Health Inc) has a market capitalization of $90.24 billion, making it a mid-cap stock.

What is ELV's price to book ratio?

Price-to-book ratio for ELV is available on our dashboard along with other valuation metrics.

Does ELV pay dividends?

Yes, ELV pays dividends with a current yield of 1.67%. Dividend payments provide income for investors in addition to potential stock price appreciation.

What is ELV's dividend yield?

ELV's dividend yield is 1.67%, calculated as annual dividends divided by the current stock price. This represents the annual return from dividends alone.

Is ELV stock a good long-term investment?

ELV's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is ELV's revenue growth rate?

Revenue growth data for ELV is available on our dashboard with detailed financial statement analysis.

Profitability metrics for ELV are available on our dashboard with complete income statement analysis.

What are the risks of investing in ELV?

Key risks for ELV include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does ELV compare to its competitors?

Compare ELV to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize ELV's performance and positioning.

What is ELV's stock price target for 2026?

Our AI model provides price targets for ELV based on fundamental analysis: Bull case $511.47 (+30%), Base case $452.46 (+15%), Bear case $354.10 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about ELV?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for ELV. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is ELV's next earnings report?

ELV reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

ELV - Elevance Health Inc

NYSE * Healthcare * Healthcare Plans

$393.44

+$11.21 (+2.93%)

About Elevance Health Inc

Elevance Health Inc (ELV) common stock

Price Chart

Loading chart...

ELV Key Statistics

Market Cap

$90.24B

P/E Ratio

17.61

Dividend Yield

1.67%

How ELV Compares to Peers

ELV ranks 2nd most undervalued by P/E ratio among peers

ELV is the smallest among peers, which may offer higher growth potential

P/E Rank

of 6

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
ELV(This stock)	$90.24B	17.6	0%	0.0%	-
UNHUnitedHealth Group	$362.83B	30.1	0%	0.0%	vs UNH
JNJJohnson &	$375.37B	17.4	0%	0.0%	vs JNJ
LLYEli Lilly	$991.62B	39.5	0%	0.0%	vs LLY
PFEPfizer Inc	$147.73B	19.8	0%	0.0%	vs PFE
ABBVAbbVie Inc	$334.34B	80.5	0%	0.0%	vs ABBV

Data Updated: July 22, 2026 at 6:21 AM EDT

Ready to invest in ELV?

Commission-free trading available. Affiliate links.

ELV Lician Score

14% confidence

4.0/10

Neutral

ELV has a Lician Score of 4/10 (Average). Areas of concern: Growth.

value

5.0

growth

2.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates ELVacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

ELV Financial Snowflake

5-axis analysis across key investment dimensions

4.4/10

Neutral

5.0

Value

Valuation vs. sector peers

2.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for ELV

Dashboard

Enter a ticker to analyze